---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-21-006450"
form_type: "8-K"
ticker: "ZOMDF"
cik: "0001684144"
company_name: "Zomedica Corp."
filed_at: "2021-09-13T23:59:59+00:00"
generated_at: "2026-06-29T04:14:09.040222+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Zomedica appoints Sean Whelan to Board; Wolfenberg resigns as director

## Summary
- Christopher Wolfenberg resigned from Zomedica Board effective Sept. 13, 2021, not due to any disagreement.
- Sean Whelan appointed to fill vacancy; will chair Audit Committee.
- Whelan is CEO of Encore Rehabilitation Services, former CFO of Diplomat and InfuSystem, and a CPA.
- Whelan received options for 800,000 common shares at $0.57/share, vesting over 4 years.
- The board change took effect immediately on September 13, 2021.

## SEC filing metadata
- accession: 0001171843-21-006450
- form_type: 8-K
- ticker: ZOMDF
- cik: 0001684144
- company_name: Zomedica Corp.
- filed_at: 2021-09-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1684144/000117184321006450/0001171843-21-006450-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1684144/000117184321006450/f8k_091321.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-21-006450
- JSON: https://secwatch.observer/filing/0001171843-21-006450.json
- Plain text: https://secwatch.observer/filing/0001171843-21-006450.txt

## Key facts
- Executive change
  Sean Whelan was appointed as member of the Board of Directors at Zomedica Corp..
  - Action: appointed
  - Role: member of the Board of Directors
  source text: On September 13, 2021, the Board appointed Sean Whelan as a member of the Board to fill the vacancy created by Mr. Wolfenberg’s resignation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1684144/000117184321006450/0001171843-21-006450-index.htm
- Executive change
  Christopher Wolfenberg resigned as member of the Board of Directors at Zomedica Corp..
  - Action: resigned
  - Role: member of the Board of Directors
  source text: On September 13, 2021, Christopher Wolfenberg resigned, effective immediately, as a member of the Board of Directors (the “Board”) of Zomedica Corp. (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1684144/000117184321006450/0001171843-21-006450-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.